Keyphrases
Cisplatin
100%
Intracavitary
100%
Abdominal Cavity
100%
Childhood Solid Tumors
100%
CDDP
100%
Chest Cavity
100%
Pharmacokinetics
30%
Pediatric Patients
30%
Intrapleural
23%
Local Recurrence
15%
Malignant Ascites
15%
Safety Toxicity
15%
Survivors
7%
Osteosarcoma
7%
Malignancy
7%
Tumor
7%
Adult Patients
7%
Safety Response
7%
Malignant Pleural Effusion
7%
Ewing Sarcoma
7%
Rhabdomyosarcoma
7%
Low Incidence
7%
Systemic Administration
7%
Serum Levels
7%
Relapsed Patients
7%
Serum Creatinine Level
7%
Pleural Effusion
7%
Temporal Baseline
7%
Pulmonary Metastasis
7%
Absolute Neutrophil Count
7%
Long-term Survivors
7%
Abdominal Tumor
7%
Pleuropulmonary Blastoma
7%
Pleural Cavity
7%
Severe Neutropenia
7%
Rhabdoid Tumor
7%
Tumor Spillage
7%
Working Diagnosis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Solid Malignant Neoplasm
100%
Pharmacokinetics
100%
Recurrent Disease
50%
Malignant Ascites
50%
Malignant Pleura Effusion
25%
Osteosarcoma
25%
Rhabdomyosarcoma
25%
Creatinine
25%
Ewing Sarcoma
25%
Systemic Administration
25%
Lung Metastasis
25%
Pleura Effusion
25%
Rhabdoid Tumor
25%
Abdominal Tumor
25%
Neoplasm
25%
Neutropenia
25%
Blastoma
25%